May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...
May 30, 2017 12:27 pm UTC| Business
CAMBRIDGE, U.K., May 30, 2017 -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces the development of two...